Estimated Incidence of Coronavirus Disease 2019 (COVID-19) Illness and Hospitalization—United States, February–September 2020
Top Cited Papers
Open Access
- 25 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 72 (12), e1010-e1017
- https://doi.org/10.1093/cid/ciaa1780
Abstract
In the United States, laboratory confirmed coronavirus disease 2019 (COVID-19) is nationally notifiable. However, reported case counts are recognized to be less than the true number of cases because detection and reporting are incomplete and can vary by disease severity, geography, and over time. To estimate the cumulative incidence SARS-CoV-2 infections, symptomatic illnesses, and hospitalizations, we adapted a simple probabilistic multiplier model. Laboratory-confirmed case counts that were reported nationally were adjusted for sources of under-detection based on testing practices in inpatient and outpatient settings and assay sensitivity. We estimated that through the end of September, 1 of every 2.5 (95% Uncertainty Interval (UI): 2.0–3.1) hospitalized infections and 1 of every 7.1 (95% UI: 5.8–9.0) non-hospitalized illnesses may have been nationally reported. Applying these multipliers to reported SARS-CoV-2 cases along with data on the prevalence of asymptomatic infection from published systematic reviews, we estimate that 2.4 million hospitalizations, 44.8 million symptomatic illnesses, and 52.9 million total infections may have occurred in the U.S. population from February 27–September 30, 2020. These preliminary estimates help demonstrate the societal and healthcare burdens of the COVID-19 pandemic and can help inform resource allocation and mitigation planning.Keywords
This publication has 21 references indexed in Scilit:
- Epidemiology of COVID-19 Among Children in ChinaPEDIATRICS, 2020
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020Eurosurveillance, 2020
- Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- The proportion of missing data should not be used to guide decisions on multiple imputationJournal of Clinical Epidemiology, 2019
- Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparednessInfluenza and Other Respiratory Viruses, 2018
- Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United StatesPLOS ONE, 2015
- Flu Near You: An Online Self-reported Influenza Surveillance System in the USAOnline Journal of Public Health Informatics, 2013
- Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009Emerging Infectious Diseases, 2009